Cargando…
Erratum to “Perrone RD, Chapman AB, Oberdhan D, et al. The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations.” Kidney Int. Rep. 2020;5:801–812
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716081/ https://www.ncbi.nlm.nih.gov/pubmed/33305145 http://dx.doi.org/10.1016/j.ekir.2020.11.011 |
Ejemplares similares
-
Corrigendum to “Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries.” Kidney Int Rep. 2020;5:263–277
Publicado: (2020) -
Corrigendum to “Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population.” Kidney Int. Rep. 2020;5:694–705
Publicado: (2020) -
Corrigendum to “Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD.” Kidney Int Rep. 2020;5:1383–1384
Publicado: (2021) -
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
por: Perrone, Ronald D., et al.
Publicado: (2020) -
Nonlinear Perron-Frobenius Theory
por: Lemmens, Bas, et al.
Publicado: (2012)